Miglitol prevents diet-induced obesity by stimulating brown adipose tissue and energy expenditure independent of preventing the digestion of carbohydrates.
Miglitol prevents diet-induced obesity by stimulating brown adipose tissue and energy expenditure independent of preventing the digestion of carbohydrates.
复制标题
米格列醇通过刺激棕色脂肪组织和能量消耗来防止饮食引起的肥胖,而与防止碳水化合物的消化无关。
作者:
Tsutomu Sasaki;M. Shimpuku;T. Kitazumi;Haruna Hiraga;Y. Nakagawa;H. Shibata;Y. Okamatsu;Osamu Kikuchi;Hye;Yuki Fujita;Jun Maruyama;V. Susanti;Hiromi Yokota;Masaki Kobayashi;M. Saito;T. Kitamura
Miglitol is an alpha-glucosidase inhibitor that improves post-prandial hyperglycemia, and it is the only drug in its class that enters the bloodstream. Anecdotally, miglitol lowers patient body weight more effectively than other alpha-glucosidase inhibitors, but the precise mechanism has not been addressed. Therefore, we analyzed the anti-obesity effects of miglitol in mice and in the HB2 brown adipocyte cell line. Miglitol prevented diet-induced obesity by stimulating energy expenditure without affecting food intake in mice. Long-term miglitol treatment dose-dependently prevented diet-induced obesity and induced mitochondrial gene expression in brown adipose tissue. The anti-obesity effect was independent of preventing carbohydrate digestion in the gastrointestinal tract. Miglitol effectively stimulated energy expenditure in mice fed a high-fat high-monocarbohydrate diet, and intraperitoneal injection of miglitol was sufficient to stimulate energy expenditure in mice. Acarbose, which is a non-absorbable alpha glucosidase inhibitor, also prevented diet-induced obesity, but through a different mechanism: it did not stimulate energy expenditure, but caused indigestion, leading to less energy absorption. Miglitol promoted adrenergic signaling in brown adipocytes in vitro. These data indicate that circulating miglitol stimulates brown adipose tissue and increases energy expenditure, thereby preventing diet-induced obesity. Further optimizing miglitol's effect on brown adipose tissue could lead to a novel anti-obesity drug.
登录
查看更多内容
影响因子:
29
作者:
Seale, Patrick;Kajimura, Shingo;Spiegelman, Bruce M.
通讯作者:
Spiegelman, Bruce M.
DOI:
10.1016/j.bbapap.2003.11.029
发表时间:
2004-03-11
影响因子:
3.2
作者:
Taylor, SS;Yang, J;Anand, G
通讯作者:
Anand, G
DOI:
10.1172/jci110541
发表时间:
1982
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Young,JB;Saville,E;Rothwell,NJ;Stock,MJ;Landsberg,L
通讯作者:
Landsberg,L
DOI:
10.1056/nejmoa0810780
发表时间:
2009-04-09
期刊:
The New England journal of medicine
影响因子:
--
作者:
Cypess AM;Lehman S;Williams G;Tal I;Rodman D;Goldfine AB;Kuo FC;Palmer EL;Tseng YH;Doria A;Kolodny GM;Kahn CR
通讯作者:
Kahn CR